CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis delta: phase 3 trial of brelovitug launches
Disease control OngoingThis Phase 3 trial tests a drug called brelovitug (BJT-778) in 80 people with chronic hepatitis delta, a serious liver infection. Participants receive either brelovitug or delayed treatment to see if the drug can lower virus levels and improve liver enzyme counts. The study is re…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug shows promise against rare liver virus
Disease control OngoingThis study tests a new medicine called BJT-778 for people with chronic hepatitis delta, a serious liver infection. About 150 adults will either start the drug right away or wait 24 weeks before starting. The goal is to see if the drug can lower the virus level and improve liver h…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control OngoingThis study follows 170 people with chronic hepatitis D who are taking bulevirtide to see how well it works over time and what side effects may occur. Researchers will track serious liver problems like liver failure, cancer, or need for transplant. The goal is to understand the dr…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC